respimat ® dry inhaler technology

Upload: yatish-karjekar

Post on 03-Jun-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/12/2019 RESPIMAT dry inhaler technology

    1/16

    RESPIMAT dry inhaler

    technology

  • 8/12/2019 RESPIMAT dry inhaler technology

    2/16

    What is Respimat Soft Mist

    Inhaler?Respimat soft mist inhaler (SMI) is propellent Free

    inhaler by Boehringer Ingelheim as innovative approach

    to inhalation therapy.

    Respimat soft mist inhaler helps to improve lung

    disposition is easy to use and preferred by patients than

    conventional MDI and DPIs

  • 8/12/2019 RESPIMAT dry inhaler technology

    3/16

    Benefits of respimat SMI innhaler Results

    Unique soft mist resulting in decreased in

    Cloud velocity

    Less impaction in the oropharynx

    decreased cloud velocity*

    Unique soft mist resulting in

    increased cloud duration

    Simplifies co-ordination of activation

    with inspiration

    Increased lung deposition Better drug targeting, allowing

    reduction of the nominal dose

    Propellant-free Less impact on the environment

    Easy to use * Simple for the patient

    High fine particle fraction Greater amount of respirable particles

    Why respimat inhaler useful???

  • 8/12/2019 RESPIMAT dry inhaler technology

    4/16

    Key features of Respimat soft mist

    inhaler

    1) High Fine-Particle Fraction :The RESPIMAT inhaler generates a medicationcloud with a high fine-particle fraction (FPF). The size of drug particles is a keyfactor in ensuring penetration of the medication into lungs.

    2) Long Cloud Duration:The RESPIMAT inhaler has demonstrated a longer cloud

    duration than pressurized metered dose inhalers (pMDIs)RESPIMAT inhaler mean cloud duration: 1.5 seconds

    pMDI cloud duration: 0.15 to 0.36 seconds

    3) Slow-Moving Aerosol Cloud :The RESPIMAT inhaler has demonstrated a slowercloud velocity (mean 0.8 m/sec) relative to pMDIs (range 2.0 m/sec to 8.4

    m/sec).4) Consistent Drug Dose : The RESPIMAT inhaler delivers a consistent drug dose

    throughout the life span of the cartridge.

    5) Higher Lung Deposition :achieve high therapeutic effect compared with othertypes of inhalers.

  • 8/12/2019 RESPIMAT dry inhaler technology

    5/16

    No Propellant :

    The RESPIMAT inhaler contains no chlorofluorocarbons

    (CFCs). This eliminates the problems associated with thevolatile propellants in pMDIs.

    Multidose Canister :

    The RESPIMAT inhaler cartridge delivers 120 metered

    actuations after preparation and priming for first-time use.The RESPIMAT inhaler includes a dose indicator combined

    with a locking mechanism that engages when the dose

    indicator has reached the end of the scale (after 120

    actuations).

  • 8/12/2019 RESPIMAT dry inhaler technology

    6/16

    External components of Respimat inhaler

  • 8/12/2019 RESPIMAT dry inhaler technology

    7/16

    Internal components of Respimat

    inhaler

  • 8/12/2019 RESPIMAT dry inhaler technology

    8/16

    HOW IT WORKS?

    A 180 twist of the device base compresses the spring.

    This draws a metered dose of drug solution through the

    capillary tube to the dosing chamber

    When the dose release button is pressed, the power from the spring

    moves the capillary tube into the dosing chamber The drug solution is forced through the uniblock

    The uniblock produces two fine jets of liquid that converge at a selected

    angle and then collide.

    The collision aerolizes the liquid to form a slow-moving cloud of

    inhalable particles, the Soft Mist

  • 8/12/2019 RESPIMAT dry inhaler technology

    9/16

  • 8/12/2019 RESPIMAT dry inhaler technology

    10/16

    Storage conditions for Respimat

    inhaler

    Store RESPIMAT inhaler at Room Temperature

    between 59F to 86F (15C to 30C).

    Do not freeze your RESPIMAT cartridge and inhaler.

  • 8/12/2019 RESPIMAT dry inhaler technology

    11/16

    Marketed formulations:

    Combivent respimat inhaler: It contains ipratonium and albuterol astwo bronchodilators for treatment of bronchitis and ephysema.

    Dosing:2 inhalations 4 times daily.

    Spiriva respimat inhaler: It contains tiotripium (long actingmuscarinic receptor antagonist) 2.5 micrograms per actuation.it is used

    for COPD diseases.

  • 8/12/2019 RESPIMAT dry inhaler technology

    12/16

    Advantages:

    No propellant

    Slow moving medicament cloud

    Consistent drug dose Cloud with high particle fraction

    Dose indicator

    Higher lung disposition than pMDIs

  • 8/12/2019 RESPIMAT dry inhaler technology

    13/16

    Disadvantages

    Not available in most countries.

    Not breath actuated.

  • 8/12/2019 RESPIMAT dry inhaler technology

    14/16

    Conclusion:

    Respimat inhaler is efficient technology as

    pulmonary drug delivery system .

    It has higher lung disposition of drug .

    No propellants are used so, it is environmental

    friendly

  • 8/12/2019 RESPIMAT dry inhaler technology

    15/16

    Referances:

    1) www.google.com

    2) www.wikipedia.in

    http://www.google.com/http://www.wikipedia.in/http://www.wikipedia.in/http://www.google.com/
  • 8/12/2019 RESPIMAT dry inhaler technology

    16/16